TB-500 makes more sense when: The injury is deep or hard to reach with an injection (spine, deep hip, cardiac tissue) You're dealing with multiple injuries at the same time Recovery involves systemic inflammation rather than something localized BPC-157 makes more sense when: The injury is easy to inject near (knee, shoulder, elbow, ankle) Gut healing is the main goal, since BPC-157's strongest documented effects are in the GI tract You're targeting a neurological issue through a localized administration route Neither peptide has human RCT data for musculoskeletal use yet
Angiogenesis accelerates the repair of damaged tissues, particularly tendons and muscles
Activity Modification During Treatment BPC-157 accelerates healing but cannot overcome continued tissue damage
Wegovy is approved for chronic weight management in obese and overweight individuals with at least one weight-related condition, such as type 2 diabetes mellitus, high blood pressure, and dyslipidemia
Firstly palpate the posterolateral corner of the acromion